Updated AAO-HNSF Guideline Sets Evidence-Based Tinnitus Management Steps

This is an updated clinical practice guideline from the American Academy of Otolaryngology-Head and Neck Surgery Foundation addressing evaluation and treatment of persistent, bothersome tinnitus (lasting 6 months or longer) in adults. The guideline states clinicians should distinguish bothersome from non-bothersome tinnitus, assess self-harm risk, avoid neuroradiologic imaging unless concerning features are present, obtain audiological evaluation, recommend hearing aid evaluation and cognitive behavioral therapy, and refer for cochlear implant evaluation when criteria are met. It also recommends against antidepressants, anticonvulsants, anxiolytics, intratympanic medications, dietary supplements, and rTMS as primary treatments for tinnitus, while offering sound enrichment and bimodal neuromodulation as optional interventions.

Most relevant for: Adults with persistent, bothersome tinnitus lasting six months or longer, including those with associated hearing loss or self-harm risk.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.